Company profile
Acusphere, Inc.
OTC: ACUS · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 44
v0.1 · 5/100 weight · pillars only
↑ listing tenure, filing timeliness · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$2.5M
Rev growth YoY (TTM)
-5.2%
Net income (FY)
—
Employees
50
as of 2026-08-31
Market cap
$49
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Acusphere, Inc.’s financial profile?
Acusphere, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Virpax Pharmaceuticals, Inc.——Coenzyme-A Inc.——Enchanted World Inc.——BC Craft Supply Co. Ltd.——Scandia, Inc.——Islet Holdings, Inc.——Neighbors
Middlesex →Key facts
CEOWilliam I. Ramage D.Phil
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersWatertown, MA
ExchangeOTC: ACUS
Employees50
IPO date2003-10-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.